Glass House Brands (GLAS) Return on Capital Employed (2021 - 2026)
Glass House Brands (GLAS) posted quarterly Return on Capital Employed of 9.86% for Q1 2026, down 230.81% quarter-over-quarter from 2.98% in Q4 2025.
Glass House Brands (GLAS) Return on Capital Employed (2021 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Return on Capital Employed for 6 consecutive years, with 9.86% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed changed N/A year-over-year to 9.86%; the TTM figure through Mar 2026 stood at 9.86% (changed N/A YoY), while the FY2025 annual figure was 5.98%, down 836.0% from the prior year.
- Return on Capital Employed slipped to 9.86% in Q1 2026 per GLAS's latest filing, from 2.98% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 27.94% in Q4 2023 and bottomed at 53.36% in Q1 2022.
- Historically, Return on Capital Employed has averaged 3.77% across 5 years, with a median of 12.75% in 2025.
- Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 1073 bps — and 2023, when it soared 7082 bps.
- Glass House Brands' Return on Capital Employed stood at 3.33% in 2022, then soared by 739 bps to 27.94% in 2023, then dropped by 21 bps to 21.99% in 2024, then plunged by 114 bps to 2.98% in 2025, then sank by 231 bps to 9.86% in 2026.
- Business Quant data shows GLAS's Return on Capital Employed at 9.86% in Q1 2026, 2.98% in Q4 2025, and 12.75% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Glass House Brands | 839.44 Mn | 820.89 Mn | 15.77 Mn | -15.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.86% |
| Dec 31, 2025 | -2.98% |
| Sep 30, 2025 | 12.75% |
| Jun 30, 2025 | 19.21% |
| Jun 30, 2024 | 21.99% |
| Dec 31, 2023 | 27.94% |
| Sep 30, 2023 | 19.99% |
| Jun 30, 2023 | 14.35% |
| Mar 31, 2023 | 17.46% |
| Dec 31, 2022 | 3.33% |
| Sep 30, 2022 | -9.67% |
| Jun 30, 2022 | -12.09% |
| Mar 31, 2022 | -53.36% |
| Dec 31, 2021 | -43.12% |
| Sep 30, 2021 | -8.33% |
| Jun 30, 2021 | -1.36% |